86 related articles for article (PubMed ID: 26592812)
1. Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.
Beck S; Muellers SN; Benzie AL; Parkin DW; Stockman BJ
Bioorg Med Chem Lett; 2015 Nov; 25(22):5036-9. PubMed ID: 26592812
[TBL] [Abstract][Full Text] [Related]
2. Ligand-Efficient Inhibitors of Trichomonas vaginalis Adenosine/Guanosine Preferring Nucleoside Ribohydrolase.
Muellers SN; Gonzalez JA; Kaur A; Sapojnikov V; Benzie AL; Brown DG; Parkin DW; Stockman BJ
ACS Infect Dis; 2019 Mar; 5(3):345-352. PubMed ID: 30701958
[TBL] [Abstract][Full Text] [Related]
3. Druggability of the guanosine/adenosine/cytidine nucleoside hydrolase from Trichomonas vaginalis.
Alam R; Barbarovich AT; Caravan W; Ismail M; Barskaya A; Parkin DW; Stockman BJ
Chem Biol Drug Des; 2018 Oct; 92(4):1736-1742. PubMed ID: 29808562
[TBL] [Abstract][Full Text] [Related]
4. Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase.
Shea TA; Burburan PJ; Matubia VN; Ramcharan SS; Rosario I; Parkin DW; Stockman BJ
Bioorg Med Chem Lett; 2014 Feb; 24(4):1080-4. PubMed ID: 24468412
[TBL] [Abstract][Full Text] [Related]
5. Discovery of Ligand-Efficient Scaffolds for the Design of Novel
Auletta S; Caravan W; Persaud JK; Thuilot SF; Brown DG; Parkin DW; Stockman BJ
ACS Omega; 2019 Oct; 4(14):16226-16232. PubMed ID: 31592163
[TBL] [Abstract][Full Text] [Related]
6. Structure-Guided Insight into the Specificity and Mechanism of a Parasitic Nucleoside Hydrolase.
Muellers SN; Nyitray MM; Reynarowych N; Saljanin E; Benzie AL; Schoenfeld AR; Stockman BJ; Allen KN
Biochemistry; 2022 Sep; 61(17):1853-1861. PubMed ID: 35994320
[No Abstract] [Full Text] [Related]
7. Direct Measurement of Nucleoside Ribohydrolase Enzyme Activities in
Stockman BJ; Ventura CA; Deykina VS; Khayan Lontscharitsch N; Saljanin E; Gil A; Canestrari M; Mahmood M
Anal Chem; 2023 Mar; 95(12):5300-5306. PubMed ID: 36917470
[TBL] [Abstract][Full Text] [Related]
8. NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases.
Stockman BJ; Kaur A; Persaud JK; Mahmood M; Thuilot SF; Emilcar MB; Canestrari M; Gonzalez JA; Auletta S; Sapojnikov V; Caravan W; Muellers SN
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31305530
[TBL] [Abstract][Full Text] [Related]
9. Isozyme-specific transition state inhibitors for the trypanosomal nucleoside hydrolases.
Parkin DW; Limberg G; Tyler PC; Furneaux RH; Chen XY; Schramm VL
Biochemistry; 1997 Mar; 36(12):3528-34. PubMed ID: 9132003
[TBL] [Abstract][Full Text] [Related]
10. Structure and function of a novel purine specific nucleoside hydrolase from Trypanosoma vivax.
Versées W; Decanniere K; Pellé R; Depoorter J; Brosens E; Parkin DW; Steyaert J
J Mol Biol; 2001 Apr; 307(5):1363-79. PubMed ID: 11292348
[TBL] [Abstract][Full Text] [Related]
11. The URH1 uridine ribohydrolase of Saccharomyces cerevisiae.
Kurtz JE; Exinger F; Erbs P; Jund R
Curr Genet; 2002 Jun; 41(3):132-41. PubMed ID: 12111094
[TBL] [Abstract][Full Text] [Related]
12. Screening and bioguided fractionation of Amaryllidaceae species with anti-Trichomonas vaginalis activity.
Vieira Pde B; Giordani RB; De Carli GA; Zuanazzi JA; Tasca T
Planta Med; 2011 Jul; 77(10):1054-9. PubMed ID: 21308614
[TBL] [Abstract][Full Text] [Related]
13. 8-Aza-immucillins as transition-state analogue inhibitors of purine nucleoside phosphorylase and nucleoside hydrolases.
Evans GB; Furneaux RH; Gainsford GJ; Hanson JC; Kicska GA; Sauve AA; Schramm VL; Tyler PC
J Med Chem; 2003 Jan; 46(1):155-60. PubMed ID: 12502369
[TBL] [Abstract][Full Text] [Related]
14. Validation of novel fluorescence assays for the routine screening of drug susceptibilities of Trichomonas vaginalis.
Natto MJ; Savioli F; Quashie NB; Dardonville C; Rodenko B; de Koning HP
J Antimicrob Chemother; 2012 Apr; 67(4):933-43. PubMed ID: 22258922
[TBL] [Abstract][Full Text] [Related]
15. Deazapurine Nucleoside Analogues for the Treatment of
Natto MJ; Hulpia F; Kalkman ER; Baillie S; Alhejeli A; Miyamoto Y; Eckmann L; Van Calenbergh S; de Koning HP
ACS Infect Dis; 2021 Jun; 7(6):1752-1764. PubMed ID: 33974405
[TBL] [Abstract][Full Text] [Related]
16. Novel metronidazole-chalcone conjugates with potential to counter drug resistance in Trichomonas vaginalis.
Anthwal A; Rajesh UC; Rawat MS; Kushwaha B; Maikhuri JP; Sharma VL; Gupta G; Rawat DS
Eur J Med Chem; 2014 May; 79():89-94. PubMed ID: 24727243
[TBL] [Abstract][Full Text] [Related]
17. N-acetyl-beta-D-hexosaminidase from Trichomonas vaginalis: substrate specificity and activity of inhibitors.
Sanon A; Tournaire-Arellano C; El Hage SY; Bories C; Caujolle R; Loiseau PM
Biomed Pharmacother; 2005 Jun; 59(5):245-8. PubMed ID: 15890491
[TBL] [Abstract][Full Text] [Related]
18. Predicting antitrichomonal activity: a computational screening using atom-based bilinear indices and experimental proofs.
Marrero-Ponce Y; Meneses-Marcel A; Castillo-Garit JA; Machado-Tugores Y; Escario JA; Barrio AG; Pereira DM; Nogal-Ruiz JJ; Arán VJ; Martínez-Fernández AR; Torrens F; Rotondo R; Ibarra-Velarde F; Alvarado YJ
Bioorg Med Chem; 2006 Oct; 14(19):6502-24. PubMed ID: 16875830
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of the antitrichomonal activity of 5-nitroimidazole derivatives by hydrogen peroxide.
Mattana A; Juliano C; Picci V; Franconi F; Cappuccinelli P
New Microbiol; 1993 Oct; 16(4):359-65. PubMed ID: 8264426
[TBL] [Abstract][Full Text] [Related]
20. Protocols for the routine screening of drug sensitivity in the human parasite Trichomonas vaginalis.
Natto MJ; Eze AA; de Koning HP
Methods Mol Biol; 2015; 1263():103-10. PubMed ID: 25618339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
